about
Toward noninvasive quantification of brain radioligand binding by combining electronic health records and dynamic PET imaging data.Model-free quantification of dynamic PET data using nonparametric deconvolution.Non-invasive quantification of brain [¹⁸F]-FDG uptake by combining medical health records and dynamic PET imaging data.Reconstructing by deconvolution plasma glucose from continuous glucose monitoring sensor data.Robust fitting of [11C]-WAY-100635 PET data.Assessment of clinical data of nonlinear stochastic deconvolution versus block-circulant singular value decomposition for quantitative dynamic susceptibility contrast magnetic resonance imaging.Empirical Bayesian estimation in graphical analysis: a voxel-based approach for the determination of the volume of distribution in PET studies.Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerationsIn vivo evaluation of [18F]FECIMBI-36, an agonist 5-HT2A/2C receptor PET radioligand in nonhuman primate.A hybrid deconvolution approach for estimation of in vivo non-displaceable binding for brain PET targets without a reference regionReference region approaches in PET: a comparative study on multiple radioligands.Modeling considerations for in vivo quantification of the dopamine transporter using [(11)C]PE2I and positron emission tomography.In vivo quantification of human serotonin 1A receptor using 11C-CUMI-101, an agonist PET radiotracer.Effects of common anesthetic agents on [18F]flumazenil binding to the GABAA receptor.Estimation of the binding potential BPND without a reference region or blood samples for brain PET studies.Lack of association between the serotonin transporter and serotonin 1A receptor: an in vivo PET imaging study in healthy adultsRadiosynthesis and in Vivo Evaluation of [11C]A1070722, a High Affinity GSK-3 PET Tracer in Primate Brain.Estimation of in vivo nonspecific binding in positron emission tomography studies without requiring a reference region.Noninvasive blood-free full quantification of positron emission tomography radioligand binding.Simultaneous estimation of input functions: an empirical study.Brain tissue selection procedures for image derived input functions derived using independent components analysis.Nonlinear stochastic regularization to characterize tissue residue function in bolus-tracking MRI: assessment and comparison with SVD, block-circulant SVD, and Tikhonov.Utility of Molecular and Structural Brain Imaging to Predict Progression from Mild Cognitive Impairment to Dementia.Non-invasive estimation of [11C]PBR28 binding potential.Pattern recognition of magnetic resonance imaging-based gray matter volume measurements classifies bipolar disorder and major depressive disorder.Longitudinal effects of cognitive behavioral therapy for depression on the neural correlates of emotion regulation.Statistical evaluation of test-retest studies in PET brain imaging.[11C]Harmine Binding to Brain Monoamine Oxidase A: Test-Retest Properties and Noninvasive Quantification.Automatic selection of arterial input function on dynamic contrast-enhanced MR images.Higher 5-HT1A autoreceptor binding as an endophenotype for major depressive disorder identified in high risk offspring - A pilot study.Kappa opioid receptor binding in major depression: A pilot studyIn vivo evaluation of [C]TMI, a COX-2 selective PET tracer, in baboonsIn Vivo Brain Imaging, Biodistribution, and Radiation Dosimetry Estimation of [C]Celecoxib, a COX-2 PET Ligand, in Nonhuman PrimatesResting regional brain activity correlates of verbal learning deficit in major depressive disorderIn vivo relationship between serotonin 1A receptor binding and gray matter volume in the healthy brain and in major depressive disorderLikelihood estimation of drug occupancy for brain PET studiesRadiosynthesis and in vivo evaluation of [11C]MOV as a PET imaging agent for COX-2Accuracy and reliability of [11C]PBR28 specific binding estimated without the use of a reference regionQuantification of Positron Emission Tomography Data Using Simultaneous Estimation of the Input Function: Validation with Venous Blood and Replication of Clinical StudiesQuantifying Brain [18F]FDG Uptake Noninvasively by Combining Medical Health Records and Dynamic PET Imaging Data
P50
Q30919459-CC6D69DA-1989-4247-96FE-1D6318F5CA24Q30931884-6917572C-4E17-478A-AA2F-6B4609A20E51Q31035341-CF034F97-296B-4325-A722-843C0AF732BCQ31133591-C1DA1285-D462-4BAF-9CBB-82D2BAA2749CQ33533741-A3AC3A4F-2133-454F-AED9-8F1CEE8A2C92Q33913248-7A12E9DC-D2A1-41D5-A9A1-FB8DE05663B0Q33958124-F13DFA6D-DE98-419E-8CF8-52AF7927184FQ33976272-9AA7E060-B569-44AA-AEB6-BC5AA34ECA04Q34545944-F959BA30-EF55-4EB9-999D-041A5737D38AQ36359775-6E696EDA-D15C-4124-AB56-2024C1540618Q36914573-025F80BE-6DC3-42CC-B3A5-357D74F8E42AQ37375428-FE26C487-BD93-4D81-AAD8-6AE3FADECA4FQ37375992-37C84E8C-8F15-4C62-A40E-1B0D5A350BFCQ37402134-78105CE1-224D-4DA5-B5BC-3759489EA3D0Q39179863-88E28815-569A-42DF-ABF1-3621872DE002Q39447750-76A2804E-19FB-4483-9B3D-85F91127B908Q41435555-02B65EC0-8CBE-4C7A-BFC1-5D7896EFDED5Q41647061-CB86F25A-5FC4-4C15-BBD1-3595A616DF63Q41882756-C09D9196-E373-42B0-959B-254B52B77465Q42414714-CFB41167-B095-4BF5-96AC-601671165B06Q43075047-B757BC9E-0F29-480C-A645-2BBEC81137D1Q45939835-DFC2D0B0-0D6C-4C08-B331-4062EEFC1876Q46133238-729E5041-5115-4ECC-A727-EC5E3DE20219Q47332736-2E80196B-4371-4CE4-BF8E-EC89CA7186D0Q47442729-6F04506F-478B-4372-B229-D06F56D0E143Q47711544-C7C5ED2C-B79E-4BED-AE43-5E248F68160EQ50051402-C563E601-C5CF-46E4-B113-D8AC2C37FD37Q50103448-BB990FDA-37BF-44E5-B486-0E9393CBA601Q51582800-27947CC1-F53C-4E0E-8365-9EBA96965255Q52558502-7BDE6E35-A05E-46F5-A84C-6DFED27D08A2Q57166284-5B0B7BCD-399B-466C-8336-DAFA0EDEEF12Q58582282-78639AA3-0624-4935-AD2E-B0A550AE15BEQ58697325-E9DA33FC-79BE-474C-94D7-BB329661BA77Q60640050-E4FBF280-C9A0-4BFE-8E83-A957408BD5DAQ88089709-9FC7D1E2-9F60-4543-8EA6-34D6CC11D150Q88648000-6A02E16F-4D58-4833-BE87-D26EF8A4DCD3Q89180619-0A8014BE-8D0B-4632-B390-A8152B55360DQ89997938-9AAFE817-3BA1-479A-B1AC-7DC4377A6040Q90393993-6087CFC5-DEBF-4810-A8C4-A51E831D175CQ90862795-BB66FE53-E887-4541-B710-CE267CE3DD0F
P50
description
researcher ORCID ID = 0000-0001-6510-0676
@en
wetenschapper
@nl
name
Francesca Zanderigo
@ast
Francesca Zanderigo
@en
Francesca Zanderigo
@es
Francesca Zanderigo
@nl
type
label
Francesca Zanderigo
@ast
Francesca Zanderigo
@en
Francesca Zanderigo
@es
Francesca Zanderigo
@nl
prefLabel
Francesca Zanderigo
@ast
Francesca Zanderigo
@en
Francesca Zanderigo
@es
Francesca Zanderigo
@nl
P1153
15520366800
P2456
P31
P496
0000-0001-6510-0676